However, the presence of abnormal dMRI measures in AD correlates with other AD biomarkers, such as amyloid PET (Kantarci et al., 2014), CSF amyloid-beta and phosphorylated tau (Amlien et al., 2013, Gold et al., 2014, Li et al., 2015). The gene discussed is MAPT; the disease is Alzheimer disease.